Document ID: chunk:federal_register_of_legislation:F2022C00588:front:0:p3
Version: federal_register_of_legislation:F2022C00588
Segment Type: other
Provision Reference: 
Character Range: 5581–8558

with a 3‑dB exchange rate for a cumulative period of at least one year, before the clinical onset of sensorineural hearing loss;
Note: dB(A) and time-weighted average (TWA) with a 3-dB exchange rate are defined in the Schedule 1 - Dictionary.
(3)          being exposed to an explosive blast within the 30 days before the clinical onset of sensorineural hearing loss;
(4)          being struck by lightning within the 30 days before the clinical onset of sensorineural hearing loss;
(5)          having:
(a)          an episode of otitic barotrauma involving the affected ear; or
(b)          decompression sickness;
within the 30 days before the clinical onset of sensorineural hearing loss;
(6)          undergoing a course of treatment with a drug or a drug from a class of drugs from the specified list of drugs, within the one year before the clinical onset of sensorineural hearing loss;
            Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(7)          having received an ototopical medication as specified, directly into the inner ear, in the presence of tympanic membrane perforation or a patent tympanostomy tube (grommet), within the 30 days before the clinical onset of sensorineural hearing loss;
            Note: ototopical medication as specified is defined in the Schedule 1 - Dictionary.
(8)          taking paracetamol or a nonsteroidal anti-inflammatory drug on an average of at least two days per week, for a continuous period of at least the one year before the clinical onset of sensorineural hearing loss;
(9)          taking a cumulative total of at least 40 grams of aspirin, or having acute salicylate toxicity, within the 30 days before the clinical onset of sensorineural hearing loss;
(10)      having a suppurative bacterial infection from the specified list of bacterial infections of the middle or inner ear, involving the affected side, within the 30 days before the clinical onset of sensorineural hearing loss;
            Note: specified list of bacterial infections is defined in the Schedule 1 - Dictionary.
(11)      having an infection with a virus from the specified list of viruses, within the 30 days before the clinical onset of sensorineural hearing loss;
            Note: specified list of viruses is defined in the Schedule 1 - Dictionary.
(12)      having viral labyrinthitis of the affected ear within the 30 days before the clinical onset of sensorineural hearing loss;
(13)      having meningitis or encephalitis within the six months before the clinical onset of sensorineural hearing loss;
(14)      having neurosyphilis before the clinical onset of sensorineural hearing loss;
(15)      having tuberculosis of the meninges, middle ear or inner ear of the affected side, before the clinical onset of sensorineural hearing loss;
(16)      having leprosy before the clinical onset of sensorineural hearing loss;
(17)      having Paget's disease of bone, affecting the petrous temporal bone or